Evidence map›Paper›PMID 26225215›Full record

ArticleAJOB primary research2011

Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception.

Yan Leykin, Paul P Christopher, Paul E Holtzheimer, Paul S Appelbaum, Helen S Mayberg, Sarah H Lisanby, Laura B Dunn

Open access · greenAbstract read
In one paragraph

Article in AJOB primary research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The effect of depression on the decision to join a clinical trial.Journal of consulting and clinical psychology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Yan LeykinUniversity of California-San Francisco.
Paul P ChristopherUniversity of Massachusetts Medical School.
Paul E HoltzheimerEmory University.
Paul S AppelbaumColumbia University.
Helen S MaybergEmory University.
Sarah H LisanbyDuke University.
Laura B DunnUniversity of California-San Francisco.
Emory University · USUniversity of California, San Francisco · USColumbia University · USDuke University · USUniversity of Massachusetts Chan Medical School · US

Funding

Does depression affect quality of decisions to participate in clinical trials?K08MH091501 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEYKIN, YAN · 2010 to 2014
$885k
Investigating structural-functional brain abnormalities in late-life depressionK23MH077869 · NIMH · EMORY UNIVERSITY · PI HOLTZHEIMER, PAUL E · 2007 to 2010
$687k
NIMH NIH HHS K08 MH091501NIMH NIH HHS K23 MH077869
6 · The paper itself

Abstract

backgroundDeep brain stimulation (DBS) for treatment-resistant depression (TRD) is the focus of great interest and numerous studies. Given the state of this research, the risks of DBS, the uncertainty of direct benefits, and the potential for therapeutic misconception (TM), examination of research participants' perspectives is critical to addressing concerns about the adequacy of consent among people with TRD.

methodsAmong 31 participants considering DBS studies at two sites, self-report questionnaires were used to examine three dimensions of TM (eight true/false items). Additional Likert-scale items assessed perceptions of risks, potential benefits, and altruistic motivations.

resultsParticipants correctly identified the surgery itself as the riskiest study procedure, although only four participants rated the surgery as "high risk." Most participants rated the entire DBS study as "moderate" or lower risk. Participants rated the likelihood of others benefiting in the future more strongly than they did the likelihood of personal benefit. Participants held positive attitudes toward research, and were moderately altruistic. Nearly two-thirds of the 31 participants (64.5%) answered at least one of the true/false TM items incorrectly.

conclusionsIndividuals considering DBS studies for TRD demonstrated reasonable perceptions of risks and benefits, distinguished among procedural risks, and expressed hopes for personal benefit as well as altruism. Findings related to TM were mixed: Participants understood the experimental stage of DBS for depression and endorsed the possibility of no personal benefit, yet there was some evidence for TM. Although these findings are reassuring, investigators must nevertheless remain vigilant about identifying and addressing potential misconceptions.

Indexed as

informed consentmajor depressionresearch benefitsresearch riskstherapeutic misconception

Identifiers

PMID26225215
PMCPMC4516276
OpenAlexW1966877859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.